HALO logo
halo search icon
Acurx Pharmaceuticals, Inc.

US$1.89

Price Change Indicator
0.01 (0.532%)
Acurx Pharmaceuticals, Inc.
ACXP · NAS

Acurx Pharmaceuticals, Inc.

Start Trading ACXP for Free

US$1.89

Price Arrow0.01 (0.532%)
20/05/2026 04:00:01 PM
All-CompaniesAll-ConsensusBig CandleHALO AllHALO Consensus ValueHALO Earnings MomentumHALO GrowthHammer Bullish+1
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Acurx Pharmaceuticals, Inc. Overview

ACXP Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Weak

Earnings

Very Strong

Growth

Earnings

Very Strong

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About ACXP

icon

Website

Acurx Pharmaceuticals, Inc.

icon

Telephone

1.917.533.1469

icon

Address

Staten Island, 259 Liberty Avenue, New York, NY 10305

Description

Acurx Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which engages in developing new antibiotics for infections caused by bacteria listed as priority pathogens. Its approach is to develop antibiotic candidates that target the DNA polymerase IIIC enzyme. Its research and development pipeline includes early-stage antibiotic candidates that target other Gram-positive bacteria, including Methicillin-Resistant Staphylococcus aureus, Vancomycin-Resistant Enterococcus and Penicillin-Resistant Streptococcus pneumoniae. The company was founded by David P. Luci, Robert G. Shawah and Robert J. DeLuccia in July 2017 and is headquartered in New York, NY.

ACXP Price Chart

Key Stats

Market Cap

US$8.08M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 1.33 - 21

Trade Value (12mth)

US$1,563,390.00

1 week

-2.08%

1 month

-18.97%

YTD

-31.88%

1 year

-77.13%

All time high

176.40

Key Fundamentals

EPS 3 yr Growth

-76.20%

EBITDA Margin

0.00%

Operating Cashflow

-$7m

Free Cash Flow Return

-230.70%

ROIC

-270.80%

Interest Coverage

0.00

Quick Ratio

3.20

Other Data

Shares Outstanding (Fully Diluted)

3m

HALO Sector

Healthcare

Next Company Report Date

18-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

ACXP Announcements

Latest Announcements

DateAnnouncements
12 May 26
16 April 26
16 April 26
10 March 26
10 March 26

ACXP Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-23.01-17.45-5.32locklocklock
EPS (Fully Diluted)
 $locklocklocklock-23.01-17.45-5.32locklocklock
Growth
 %locklocklocklock-2.924.269.5locklocklock
PE
 XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
 XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Acurx Pharmaceuticals, Inc. (ACXP:NAS)?
Halo FAQ
The current share price of Acurx Pharmaceuticals, Inc. (ACXP:NAS) is USD$1.89.
What is the 52-week high share price for Acurx Pharmaceuticals, Inc. (ACXP:NAS)?
Halo FAQ
The 52-week high share price for Acurx Pharmaceuticals, Inc. (ACXP:NAS) is USD$21.00.
What is the 52-week low share price for Acurx Pharmaceuticals, Inc. (ACXP:NAS)?
Halo FAQ
The 52-week low share price for Acurx Pharmaceuticals, Inc. (ACXP:NAS) is USD$1.33.
What is the dividend yield for Acurx Pharmaceuticals, Inc. (ACXP:NAS)?
Halo FAQ
Acurx Pharmaceuticals, Inc. (ACXP:NAS) does not pay a dividend.
What was Acurx Pharmaceuticals, Inc. (ACXP:NAS) last dividend payment?
Halo FAQ
Acurx Pharmaceuticals, Inc. (ACXP:NAS) does not pay a dividend.
What is the franking level for Acurx Pharmaceuticals, Inc. (ACXP:NAS)?
Halo FAQ
Acurx Pharmaceuticals, Inc. (ACXP:NAS) has a franking level of 0.00%.
In which sector is Acurx Pharmaceuticals, Inc. (ACXP:NAS) classified?
Halo FAQ
Acurx Pharmaceuticals, Inc. (ACXP:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial